Immunotherapy for cervical cancer: Research status and clinical potential
The high-risk types of human papillomavirus (HPV) have been found to be associated with
most cervical cancers and play an essential role in the pathogenesis of the disease. Despite …
most cervical cancers and play an essential role in the pathogenesis of the disease. Despite …
Preventative and therapeutic vaccines for cervical cancer
'High-risk'genotypes of the human papillomavirus (HPV), most commonly HPV genotype 16,
are the primary etiologic agents of cervical cancer. Indeed HPV DNA is detected in 99% of …
are the primary etiologic agents of cervical cancer. Indeed HPV DNA is detected in 99% of …
Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research
Cervical cancer is the fourth most lethal women's cancer worldwide. Current treatments
against cervical cancer include surgery, radiotherapy, chemotherapy, and anti-angiogenic …
against cervical cancer include surgery, radiotherapy, chemotherapy, and anti-angiogenic …
Vaccines against human papillomavirus and cervical cancer: promises and challenges
Abstract Learning Objectives After completing this course, the reader will be able to: Discuss
the epidemiology and pathogenesis of HPV and HPV-associated diseases. Explain the …
the epidemiology and pathogenesis of HPV and HPV-associated diseases. Explain the …
Vaccination strategies for the treatment and prevention of cervical cancer
C Schreckenberger, AM Kaufmann - Current opinion in oncology, 2004 - journals.lww.com
While successful prophylactic HPV vaccines have entered large clinical trials, therapeutic
HPV vaccines, in spite of T cell induction, lack clinical responses due to the problem of tumor …
HPV vaccines, in spite of T cell induction, lack clinical responses due to the problem of tumor …
The use of both therapeutic and prophylactic vaccines in the therapy of papillomavirus disease
AR Garbuglia, D Lapa, C Sias… - Frontiers in …, 2020 - frontiersin.org
Human papillomavirus (HPV) is the most common sexually transmitted virus. The high-risk
HPV types (ie, HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59) are considered to be the …
HPV types (ie, HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59) are considered to be the …
HPV and therapeutic vaccines: where are we in 2010?
The discovery of human papillomavirus (HPV) as a necessary etiological factor for cervical
cancer has spurred the development of preventive and therapeutic HPV vaccines for the …
cancer has spurred the development of preventive and therapeutic HPV vaccines for the …
Immunology of HPV-mediated cervical cancer: current understanding
Human papilloma virus (HPV) has emerged as a primary cause of cervical cancer
worldwide. HPV is a relatively small (55 nm in diameter) and non-enveloped virus …
worldwide. HPV is a relatively small (55 nm in diameter) and non-enveloped virus …
Different spectra of therapeutic vaccine development against HPV infections
Human papillomaviruses (HPVs) are simple, non-enveloped, double-stranded DNA viruses
and responsible for an enormous global burden of genital disease. HPV is annually …
and responsible for an enormous global burden of genital disease. HPV is annually …
Cervical cancer immunotherapy: facts and hopes
It is a sad fact that despite being almost completely preventable through human
papillomavirus (HPV) vaccination and screening, cervical cancer remains the fourth most …
papillomavirus (HPV) vaccination and screening, cervical cancer remains the fourth most …